Home
History
Study Overview
Forms & Common Data Elements
Abstracts
Publications
Study Roster
Committees
Latest News & Meetings
StudyCTMS
Contact Us
Lung HIV Research Abstracts for Posters and Oral Presentations American Thoracic Society International Conference Posters and Presentations ATS 2010, New Orleans
 
  1. Abs. ID/Title: #1724 - Obstructive Lung Disease Is Unrecognized in an Inner City Population
    Session: C25 - Chronic Obstructive Pulmonary Disease: Updates on Epidemiology and Clinical Phenotypes
    Session Type: Poster Discussion Session- Poster Presentation
    Presenting Author: M. Bradley Drummond
    Date: Tuesday, May 18, 2010
    Time: 8:15 AM-10:45 AM
  2. Abs. ID/Title: #1394 - Decline of Forced Expiratory Volume in 1 Second in an Urban Population of HIV-Infected and Uninfected Injection Drug Users
    Session: C104 - HIV Associated Lung Disease Including Pneumocystis
    Session Type: Poster Discussion Session- Poster Presentation
    Presenting Author: Mariah M. Marshall
    Date: Tuesday, May 18, 2010
    Time: 1:30 PM-4:00 PM
  3. Abs. ID/Title: #2852 - Analysis of Pulmonary Function Decline in Two Cohorts of HIV-Infected Subjects. Is HAART Making a Difference?
    Session: C104 - HIV Associated Lung Disease Including Pneumocystis
    Session Type: Poster Discussion Session- Poster Presentation
    Presenting Author: (Lung HIV site 004 Ohio State University)
    Date: Tuesday, May 18, 2010
    Time: 1:30 PM-4:00 PM
  4. Abs. ID/Title: #6849 - Correlation of inflammatory BAL biomarkers with pulmonary function testing in HIV+ smokers
    Session: C104 - HIV Associated Lung Disease Including Pneumocystis
    Session Type: Poster Discussion Session- Poster Presentation
    Presenting Author: (Lung HIV site 004 Ohio State University)
    Date: Tuesday, May 18, 2010
    Time: 1:30 PM-4:00 PM
  5. Abs. ID/Title: #6289 - Body Composition Changes in HIV+ Smokers Undergoing Smoking Cessation
    Session: B26 - Barriers and Interventions for Smoking Cessation
    Session Type: Poster Discussion Session- Poster Presentation
    Date: Monday, May 17, 2010
    Time: 8:15 AM-10:45 AM
  6. Abs. ID/Title: #1922 - Low Prevalence of Pneumocystis Pneumonia (PCP) but High Prevalence of Pneumocystis Dihydropteroate Synthase (DHPS) Gene Mutations in HIV-Infected Persons in Uganda
    Session: C104 - HIV Associated Lung Disease Including Pneumocystis
    Session Type: Poster Discussion Session- Poster Presentation
    Presenting Author: Laurence Huang
    Date: Tuesday, May 18, 2010
    Time: 1:30 PM-4:00 PM
  7. Abs. ID/Title: #4519 - HIV-1 Nef signature sequences are a feature of HIV-related pulmonary hypertension: a genetic translational tool?
    Session: C104 - HIV Associated Lung Disease Including Pneumocystis Session Type: Poster Discussion Session- Poster Presentation
    Presenting Author: Sharilyn Almodovar
    Date: Tuesday, May 18, 2010
    Time: 1:30 PM-4:00 PM
  8. Abs. ID/Title: #227 - Incidence and Mortality of MICU Admission in HIV Infected (HIV+) and Non-Infected (HIV-) Veterans
    Session: C104 - HIV Associated Lung Disease Including Pneumocystis Session Type: Poster Discussion Session- Poster Presentation
    Presenting Author: Kathleen Akgun
    Date: Tuesday, May 18, 2010
    Time: 1:30 PM-4:00 PM
  9. Abs. ID/Title: #891 - Risk Factors for MICU Admission among HIV+ Patients
    Session: C104 - HIV Associated Lung Disease Including Pneumocystis
    Session Type: Poster Discussion Session- Poster Presentation
    Presenting author: Kathleen Akgun (Kristina Crothers)
    Date: Tuesday, May 18, 2010
    Time: 1:30 PM-4:00 PM
  10. Abs. ID/Title: #4200 - Relationship of Pneumocystis KEX1 Antibody Responses to Pneumocystis Colonization in Health Care Workers
    Session: C104 - HIV Associated Lung Disease Including Pneumocystis
    Session Type: Poster Discussion Session- Poster Presentation
    Presenting Author: Jan Koff
    Date: Tuesday, May 18, 2010
  11. Abs. ID/Title: #1083 - Clinical Significance of Normal Chest Radiographs among HIV-infected TB Suspects in Uganda
    Session: C104 - HIV Associated Lung Disease Including Pneumocystis
    Session Type: Poster Discussion Session- Poster Presentation
    Presenting author: Samuel Yoo
    Date: Tuesday, May 18, 2010
 
Lung HIV Research Abstracts for posters and oral presentations American Thoracic Society International Conference Posters and Presentations ATS 2011, Denver
 
  1. Oral Anti-Microbial Rinse Before Sputum Collection Reduces Culture Contamination, But Also Smear And Culture Positivity For Mycobacterium Tuberculosis, [Publication Page: A1206]. N. Kalema1, S. Den Boon1, J.L. Davis2, A. Cattamanchi2, N.D. Walter3, A.O. Andama1, W. Worodria1, L. Huang4
  2. Performance Of Bronchoalveolar Lavage Enzyme-Linked Immunospot For Diagnosis Of Smear-Negative Tuberculosis In HIV-Infected Patients, [Publication Page: A1202]. A. Cattamanchi1, I. Ssewanyana2, R. Magala2, C.R. Miller1, S. den Boon2, J.L. Davis1, W. Worodria2, L. Huang1, H. Cao3
  3. Serologic Response To Recombinant Pneumocystis Jirovecii Major Surface Antigen In A Ugandan Cohort, [Publication Page: A4142]. R.J. Blount1, L.G. Jarlsberg1, K.R. Daly2, W. Worodria3, K. Djawe2, J.L. Davis1, A. Cattamanchi1, S. den Boon3, J. Koch2, P.D. Walzer2, L. Huang1
  4. Prevalence And Outcomes Of Cryptococcal Co-Infection In HIV Sero-Positive Patients With Suspected Pneumonia At Mulago Hospital Using Serum Cryptococcal Antigen (CRAG) Testing, [Publication Page: A4148]. A.O. Andama1, S. den Boon1, D. Meya1, A. Cattamanchi2, W. Worodria1, J.L. Davis2, N.D. Walter3, S. Yoo1, B. Haller1, L. Huang2
  5. Influence Of Climatic And Ambient Air Pollutant Factors On Pneumocystis Jirovecii Pneumonia (PCP) In HIV+ Patients From San Francisco Using A Case-Crossover Design, [Publication Page: A4145]. K. Djawe1, L.L. Levin1, A. Swartzman2, S. Fong2, B. Brenna Roth2, A. Subramanian2, K. Grieco2, L.G. Jarlsberg2, L. Huang2, P.D. Walzer1
  6. Have We Plateaued? Outcomes Of HIV-Infected Patients Admitted To The Intensive Care Unit In The Combined Antiretroviral Therapy Era, [Publication Page: A6271]. C. Yoon, D. Weir, M. Greene, L.G. Jarlsberg, J.L. Davis, L. Huang
  7. Persistent Airway Microbiome In HIV-positive Patients With Acute Pneumonia And On Antibiotics, [Publication Page: A6256]. D. Huang1, S. Iwai2, M. Fei2, S. Fong2, A. Subramanian2, K. Grieco2, S.V. Lynch2, L. Huang2 (also Lung HIV Microbiome Project)
  8. 8. Prevalence Of Viral Infections In HIV-Infected Individuals With Opportunistic Pneumonia In Kampala, Uganda, [Publication Page: A6255]. N. Roubinian1, L. Huang1, E. Chen1, W. Worodria2, S. Yoo2, D. Huang1, S. Fong1, E. Kim1, S. Den Boon2, A. Cattamanchi1, J.L. Davis1, S. Lynch1, C. Chiu1 (also Lung HIV Microbiome Project)
 
Additional Lung HIV Abstracts for Journals, Presentations and Poster Sessions and Published Articles/Papers
 
  1. Akgun KM, Pisani MA, Fried TR, Butt AA, Gibert CL, Rimland D, Huang L, Justice AC, Rodriguez-Barradas MC, and Crothers K. “Impact of Age on Medical Intensive Care Unit (MICU) Admissions In HIV-Infected Patients.” American Thoracic Society International Conference, Denver, CO, May 2011. (Poster Discussion Session)
  2. Almodovar S, Humbert M, Voelkel N, and Flores SC. “Association between HIV-related pulmonary arterial hypertension and particular signature sequences in the HIV-1 Nef gene in vivo.” UCHSC-Department of Medicine Fifth Annual Research Day, November 3, 2007. (Poster Discussion Session)
  3. Ambrose BK, Kirk GD, Gange SJ, Apelberg BJ, Mehta SH, and Samet JM. “Determinants of Smoking Cessation Among a Cohort of Injection Drug Users at High Risk of HIV Infection in Baltimore, MD (1988-2008).” 4th Annual Johns Hopkins Addictions and Infectious Disease Conference, Baltimore, May 2010. (Poster)
  4. Ambrose BK, Marshall MM, Apelberg BJ, and Kirk GD. “Tobacco Use and Attempts to Quit Smoking Among Injection Drug Users at High Risk of HIV-infection in Baltimore, MD.” International AIDS Conference, Vienna, Austria, July 2010. (Poster).
  5. Almodovar S, Hakar M, Allshouse AA, Fong S, Arjomandi M, Hsue PY, Huang L, and Flores SC. HIV-1 NEF In HIV-Associated Pulmonary Hypertension: Are There Lung-Specific Nef Signature Sequences? Am. J. Respir. Crit. Care Med., May 2011; 183: A6260.Denver, Colorado.
  6. Almodovar S, Morelli J, Hakar M, Gilman J, Niemeyer B, Flores AC, Sokas C, Hsue PY, Flores SC. Expediting diagnosis of HIV-related pulmonary hypertension from the bench: HIV-1 nef sequences as genetic translational tools. Presented at the Thomas L. Petty Aspen Lung Conference, 53rd Annual Meeting on "Systems Biology of Lung Diseases - Progress in the 'Omics' Era," 2010, Aspen, Colorado.
  7. Almodovar S, Allshouse A, Knight R, Roemer S, Voelkel NF, Hsue PY, Humbert M, Flores SC. HIV-1 Nef Signature Sequences Are A Feature Of HIVrelated Pulmonary Hypertension: A Genetic Translational Tool? Am J Respir Crit Care Med 181;2010:A5209. New Orleans, Louisiana.
  8. Almodovar S, Simonneau G, Humbert M, Flores S. Association between HIV-1 Nef signature sequences and HIV-related pulmonary hypertension. American Journal of Respiration and Clinical Care Medicine (2008); 77:A440. Toronto
  9. Ambrose BK, Gange SJ, Apellberg BJ, Mehta, SH, Samet JM, and Kirk GD. “The Impact of Injection Drug Use Cessation and Antiretroviral Therapy on Smoking Cessation Among HIV-infected Injection Drug Users in Baltimore, MD 1988-2008.” 18th International AIDS Conference Meeting in Vienna, Austria, July 2010. (Poster)
  10. Ambrose BK, Westergaard RP, Jonas M, and Kirk GD. “Provider Beliefs and Integration of Tobacco Cessation Strategies into the Clinical Care of HIV-infected Patients.” 18th International AIDS Conference Meeting in Vienna, Austria, July 2010. (Poster)
  11. Ambrose BK. “Tobacco Cessation at the Intersection of the Injection Drug Use, HIV and Tobacco Use Epidemics in Baltimore, MD.” Institute for Global Tobacco Control Research Symposium, Johhns Hopkins Bloomberg School of Public Health. Baltimore, MD, September 2010.
  12. Ambrose BK, Pearson J, Marshall MM, Apelberg BJ, Mehta SH, and Kirk GD. “Tobacco Use and Attempts to Q uit Smoking Among Injection Drug Users at High-risk of HIV infection in 2009, Baltimore, MD.” 138th Annual American Public Health Association Meeting in Denver, CO, November 2010. (Oral presentation)
  13. Campo M, Shahrir S, Oursler KA, Rimland D, Soo Hoo G, Brown S, Goetz M, Huang L, Au DH, Rodriguez-Barradas, Sharafkhaneh A, Akgun KM, and Crothers K. “Respiratory Symptoms Are Associated With Decreased Performance On 6-Minute Walk Test Among HIV-Infected Patients,” American Thoracic Society International Conference, Denver, CO, May 2011. (Poster Discussion Session)
  14. Daly KR, Morris A, Kpandja MD, Levin L, and Walzer PD. “Long-term Serologic Responses to Pneumocystis (Pc) in the Multicenter AIDS Cohort Study (MACS) patients.” Am J Resp Crit Care Med (2008); 180:A837.
  15. Drummond MB, McCormack MC, Ricketts EP, Wise RA, Kirk GD, and Merlo CA. “Impact of Chronic Obstructive Pulmonary Disease on Health Status Scores in HIV.” American Thoracic Society International Conference, Toronto, Canada, May 2008. (Poster discussion).
  16. Drummond MB, Kirk GD, Astemboroski J, McCormack MC, Marshall MM, Mehta SH, Wise RA and Merlo CA. “Prevalence, Treatment and Risk Factors for Unrecognized Obstructive Lung Disease Among Current and Former Urban Drug Users.” American Thoracic Society International Conference, New Orleans, LA, May 2010 (Poster discussion).
  17. Flores SC. “HIV and the Nef Protein: Pathogenesis of a Deadly Disease.” American College of Chest Physicians (ACCP) Meeting (CHEST 2010), Vancouver, CA, Oct 29th, Nov 4th, 2010
  18. Flores SC. “Emerging Concepts on PAH: HIV and the Nef Protein.” American Heart Association Meeting (AHA 2010), Chicago, IL, Nov 15, 2010.
  19. Flores SC and Almodovar S. “HIV-1 Nef Signature Sequences and Pulmonary Arterial Hypertension: Structure-function Relationships to Pathogenesis.” HIV and Therapeutic Interventions Session of the Annual American Society for Biochemistry and Molecular Biology Meeting, New Orleans, LA. FASEB J (April 2009); 23:331.1.
  20. Gingo MR, Balasubramani GK, Kingsley L, Rinaldo CR, Phair J, Sutton S, Detels R Margolick J, and Morris A. “Pulmonary Disease in HIV During the HAART Era.” Am J Resp Crit Care Med (2009); 179:A2278.
  21. Gingo MR, Balasubramani GK, Kingsley L, Kleerup E, Seaberg E, and Morris A. “HIV Infection and Prevalence of Pulmonary Disease in the Multicenter AIDS Cohort Study.” 19th Conference on Retroviruses and Opportunistic Infections, 2012.
  22. Kirk GD., “HIV-associated Malignancies in Baltimore.” Research Matters Conference 2009: A Conference on the Statewide Academic Health Centers Cancer Initiatives, University of Maryland Greenbaum Cancer Center, Baltimore, MD, November 2009.
  23. Kirk GD. “HIV, Smoking and Cancer in Baltimore.” Maryland State Department of Health, Cancer Registry Speaker Series, Baltimore, MD, November 2009.
  24. Kirk GD. “The Use of GPS-linked EMA and Neighborhood Indicators of Stress and Drug Use. New Frontiers in Measurement: Phenotypes, Endophenotypes, and Envirotypes for Genetic and Behavioral Studies of Nicotine Dependence.” Society of Nicotine and Tobacco Research, Baltimore, MD, February 2010 (Oral presentation).
  25. Kirk GD. “HIV Infection Increases Risk for Lung Cancer and COPD: Results from SHIELD (Study of HIV Infection in the Etiology of Lung Disease).” American Thoracic Society International Conference, New Orleans, LA, May 2010 (Oral presentation).
  26. Kobayashi H, Nolan A, Naveed B, Hoshino Y, Hoshino S, Rom WN, and Weiden MD. “Caspase 6 Cleaves the Macrophage Inhibitor IRAK-M in Contact Dependent Innate Immune Activation.” [Abstract] Am J Respir Crit Care Med (April 2009); 179:A5689. Offline #J017498226.
  27. Kobayashi H, Nolan A, Naveed B, Comfort AL, Rom WN, Hoshino Y, and Weiden MD. “Neutrophils Activate Alveolar Macrophages by Producing Caspase-6 Mediated Cleavage of Interleukin-1 Associated Kinase-M (IRAK-M) In Tuberculosis.” [Abstract] Am J Respir Crit Care Med (2010); 181:A3221.
  28. Lucht LA, Oleksiuk M, Gingo M, George MP, Kessinger C, Kleerup E, Huang L, Morris A. Pulmonary Function In HIV-Infected And HIV-Negative Persons In The Era Of Antiretroviral Therapy, Am J Respir Crit Care Med (2010); 181: A6264
  29. Marshall MM, Kirk GD, Mehta SH, Engels EA. “Tobacco Use and Nicotine Dependence Among HIV-infected and Uninfected Injection Drug Users.” 3rd Annual Johns Hopkins Addictions and Infectious Disease Conference, Baltimore, MD, April 2009. (Poster)
  30. Marshall MM, Kirk GD, Astemboski JA, Mehta SH, Drummond MB, and Merlo CA. “Decline of Forced Expiratory Volume in 1 Second in an Urban Population of HIV-Infected and Uninfected Injection Drug Users.” American Thoracic Society International Conference, New Orleans, LA, May 2010 (Poster discussion)
  31. Merlo C, Hague JC, Ricketts E, Mehta SH, Engels EA, Wise R, and Kirk GD. “Prevalence and Risk Factors for COPD Among HIV-infected and HIV-uninfected At-risk Persons.” American Thoracic Society International Conference, Toronto, CA, May 2008. (Poster)
  32. Morris A. Lung Complications of HIV. Pittsburgh International Lung Conference, Pittsburgh, PA, 10/9/09.
  33. Morris A. From PCP to COPD: Changes in Pulmonary Complications of HIV During the AIDS Epidemic. The National Heart Lung and Blood Institute Lung HIV Study: A New Model for Collaborative Clinical and Translational Research. American Thoracic Society International Conference, New Orleans, LA, 5/19/10.
  34. Naveed B, Weiden MD, Nolan A, Kang GS, Rom WN, and Chen LC. “Costimulatory Molecules in the Inflammatory Response to PM2.5 Exposure.” [Abstract] Am J Respir Crit Care Med (April 2009); 179:A3138. Offline #J0174981.
  35. Naveed B, Weiden MD, Rom WN, Prezant DJ, Comfort A, Chen L, Kwon S, Chen Y, Gordon T, and Nolan A.”WTC PM2.5 Stimulates a More Intense Inflammatory Response in Human BAL Cells than Other Ambient PM2.5 from NYC and Surrounding Environs.” [Abstract] Clinical & Translational Science (2010); 3(2):S48. EMBASE:70206222 #J0191004.
  36. Naveed B, Weiden MD, Rom WN, Prezant DJ, Comfort, Ashley L, Chen Y, Kwon S, Chen LC, Gordon T, and Nolan A. “WTC PM2.5 Stimulates a More Intense Inflammatory Response In Human BAL Cells Than Other Ambient PM2.5 From NYC and Surrounding Environs.” [Abstract] Am J Respir Crit Care Med (2010); 181:A1158.
  37. Salter ML, Ahmed M, Mehta SH, and Kirk GD. “HIV Infection and Immune Suppression are Associated with Higher Burden of Mulitmorbidity among Aging IDUs in Baltimore, MD.” 1st International Workshop on HIV and Aging, Baltimore, MD, October 2010. (Oral presentation)
  38. Segal L, Kulkarni R, Nolan A, Weiden MD, Tse DB, and Rom WN. ”Regulatory T cells and Th17 Cells in Bronchoalveolar Lavage.” [Abstract] Am J Respir Crit Care Med (2011); 183:A4799. Offline #J0224138.
  39. Segal L, Kulkarni R, Fujita Y, Nolan A, Rom WN, and Weiden M. “Azithromycin Suppresses Inflammatory Cytokines and Induces Inhibitory Transcription Factors in Alveolar Macrophages.” [Abstract] Am J Respir Crit Care Med (2011); 183:A2853.
  40. Shahrir S, Tindle HA, Rodriguez-Barradas MC, Au DH, Wongtrakool C, Soo Hoo G, Akgun KM, Huang L, and Crothers K. “Smoking Behaviors And Utilization Of Smoking Cessation Therapies With Quit Attempts Among Current Compared To Former Smokers.” American Thoracic Society International Conference, Denver, CO, May 2011. (Poster Discussion Session)
  41. Shiels MS, Cole SR, Mehta SH, and Kirk GD. “Risk of Smoking-associated Cancers and Lung Cancer Survival among HIV-positive and HIV-negative Injection Drug Users.” Society of Epidemiologic Research Conference, Seattle, WA, June 2009. (Poster).
  42. Sigel K, Wisnewsky J, Justice AC, Brown S, Butt AA, Crystal S, Rimland D, Rodriguez-Barradas, and Crothers K. “HIV is an Independent Risk Factor for Incident Lung Cancer Among HIV-Infected Veterans,” 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, Feb 2010. (Oral Presentation)
  43. Sigel K, Brown S, Wisnivesky J, Akgun K, Kim JW, Rodriguez-Barradas MC, Soo Hoo G, Shahrir S, and Crothers K. “Chest CT Scan Findings and Implications for Lung Cancer Screening in Asymptomatic HIV Infected Patients.” Accepted for presentation at a themed oral session and as a poster at the Conference on Retroviruses and Opportunistic infections, Seattle, WA, March 2012.
 
 
 
Designed and maintained by Clinical Trials and Surveys Corp. - Copyright 2008